Discover how glioblastoma's embryonic-like stem cells use immune evasion tactics to survive treatment and how new research is uncovering ways to target them.
Explore how monoclonal T-cell receptor drugs are transforming cancer treatment by targeting intracellular proteins that traditional therapies cannot reach.
Discover how lentivirus display technology is transforming cells into living billboards for antibodies, revolutionizing immunotherapy and disease treatment.
Scientists are using a revolutionary imaging technique to find the perfect targets for next-generation CAR T cell therapies for glioblastoma.
Exploring IL-2's evolution from toxic cancer drug to precision weapon against acute myeloid leukemia relapse during remission.
Explore how monoclonal antibodies are transforming cancer treatment through targeted therapy, with the latest breakthroughs in 2025.
Discover how AFM13, a tetravalent bispecific antibody, is transforming treatment for relapsed/refractory Hodgkin lymphoma by harnessing NK cells.